Ekso BionicsEKSO
About: Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.
Employees: 66
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
150% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 4
33% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 6
16% more funds holding
Funds holding: 32 [Q4 2024] → 37 (+5) [Q1 2025]
3.11% less ownership
Funds ownership: 18.36% [Q4 2024] → 15.25% (-3.11%) [Q1 2025]
38% less capital invested
Capital invested by funds: $2.46M [Q4 2024] → $1.53M (-$939K) [Q1 2025]
Research analyst outlook
1 Wall Street Analyst provided 1 year price targets over the past 3 months
1 analyst rating
HC Wainwright & Co. Swayampakula Ramakanth | 1,463%upside $60 | Buy Maintained | 6 May 2025 |
Financial journalist opinion









